Splenectomy is an effective therapy for steroid-refractory or dependent immune
thrombocytopenia (ITP). With the advent of medical alternatives such as rituximab and …

Splenectomy has been a standard treatment for adult patients with idiopathic
thrombocytopenic purpura (ITP) for more than 50 years. However, the durability of …

Splenectomy is a powerful therapeutic procedure in a wide variety of medical disorders
provided that it is not undertaken lightly and the risks are weighed against the potential …

Our goal is to set forth our opinion of the best approach to managing adults with primary
idiopathic (autoimmune) thrombocytopenic purpura (ITP), with emphasis on the word …

Whether rituximab could effectively and safely avoid splenectomy for adults with chronic
immune thrombocytopenic purpura (ITP) remains unresolved. A multicenter, prospective …

Primary immune thrombocytopenic purpura (ITP), also referred to as idiopathic
thrombocytopenic purpura, is an organ-specific autoimmune disorder in which …

BACKGROUND AND OBJECTIVES: Immune thrombocytopenic purpura (ITP) is an acquired
autoimmune disease characterized by platelet destruction. Glucocorticoids are the first …

Splenectomy is the only treatment of ITP known to have “curative” effects in a substantial
fraction of patients. However, the true long‐term outcome is uncertain and controversial …

Background Immune thrombocytopenia (ITP) is a heterogeneous acquired disorder
characterized by isolated thrombocytopenia whose exact pathogenesis is not yet clear …

Idiopathic thrombocytopenic purpura (ITP) is a common hematologic disorder manifested by
immune-mediated thrombocytopenia. The diagnosis remains one of exclusion, after other …